DocGo Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $70.1M
- Price
- $0.7101
- % Change (Daily % change from the live per-ticker quote feed.)
- +6.40%
- Volume
- 1.9M
About
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Quick stats
Shares outstanding98.8M
Computed float95.8M
Float / shares97.0%
Cash runway (months)-4.6
Key info
SectorHealthcare
IndustryMedical - Care Facilities
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001822359
Websitehttps://www.docgo.com
AI Summary
AI-generated1/23
majormixedearnings
DocGo Announces Second Quarter 2026 Results
DocGo reported Q2 2026 revenue of $73.4 million, down 9% year-over-year due to the wind-down of migrant programs, but core business revenue grew 19% excluding those programs.
Adjusted EBITDA was ($6.3) million, widening slightly from the prior year, and the company cut its full-year 2026 adjusted EBITDA guidance to a range of ($17 million) to ($22 million).
Simultaneously, DocGo announced a definitive agreement to acquire Hicuity Health for approximately $52 million in debt assumption and secured a new $50 million term loan commitment from Perceptive Advisors.
Red flags
- Adjusted EBITDA guidance lowered from ($5-$10)M to ($17-$22)M
- Net loss widened to ($18.0)M from ($13.3)M year-over-year
- Unrestricted cash decreased to $25.2M from $35.7M quarter-over-quarter